doi: 10.1111/j.1476-5381.2009.00486.x 60 Diz-ChavesYHerrera-PrezSGonzlez-MatasLCMalloF
The psychological component you've highlighted deserves far more clinical attention
Milder DA, et al
Lund A, Vilsboll T, Bagger JI et al (2011) The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes
Other state and private insurers have adopted similar stances for the drugs, which can cost patients more than $1,000 monthly out-of-pocket
1 Later, the American Association for the Study of Liver Diseases led the adoption of a new multisociety Delphi consensus in 2023, proposing metabolic dysfunction-associated steatotic liver disease (MASLD) as another replacement term for nonalcoholic fatty liver disease